417 related articles for article (PubMed ID: 26276025)
21. Enterovirus-A71 exploits peripherin and Rac1 to invade the central nervous system.
Lim ZQ; Ng QY; Oo Y; Chu JJH; Ng SY; Sze SK; Alonso S
EMBO Rep; 2021 Jun; 22(6):e51777. PubMed ID: 33871166
[TBL] [Abstract][Full Text] [Related]
22. Tribbles pseudokinase 3 promotes enterovirus A71 infection via dual mechanisms.
Wang H; Li K; Cui B; Yan H; Wu S; Wang K; Yang G; Jiang J; Li Y
Emerg Microbes Infect; 2024 Dec; 13(1):2307514. PubMed ID: 38240287
[TBL] [Abstract][Full Text] [Related]
23. Coxsackievirus A16 in a 1-Day-Old Mouse Model of Central Nervous System Infection Shows Lower Neurovirulence than Enterovirus A71.
Hooi YT; Ong KC; Tan SH; Perera D; Wong KT
J Comp Pathol; 2020 Apr; 176():19-32. PubMed ID: 32359633
[TBL] [Abstract][Full Text] [Related]
24. Acute Flaccid Paralysis and Enteroviral Infections.
Bitnun A; Yeh EA
Curr Infect Dis Rep; 2018 Jun; 20(9):34. PubMed ID: 29959591
[TBL] [Abstract][Full Text] [Related]
25. Enterovirus A71 and coxsackievirus A16 show different replication kinetics in human neuronal and non-neuronal cell lines.
Yogarajah T; Ong KC; Perera D; Wong KT
Arch Virol; 2017 Mar; 162(3):727-737. PubMed ID: 27878462
[TBL] [Abstract][Full Text] [Related]
26. Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development.
Chang YK; Chen KH; Chen KT
Rev Inst Med Trop Sao Paulo; 2018 Nov; 60():e70. PubMed ID: 30427405
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary and central nervous system pathology in fatal cases of hand foot and mouth disease caused by enterovirus A71 infection.
Wang Z; Nicholls JM; Liu F; Wang J; Feng Z; Liu D; Sun Y; Zhou C; Li Y; Li H; Qi S; Huang X; Sui J; Liao Q; Peiris M; Yu H; Wang Y
Pathology; 2016 Apr; 48(3):267-74. PubMed ID: 27020504
[TBL] [Abstract][Full Text] [Related]
28. Human tryptophanyl-tRNA synthetase is an IFN-γ-inducible entry factor for Enterovirus.
Yeung ML; Jia L; Yip CCY; Chan JFW; Teng JLL; Chan KH; Cai JP; Zhang C; Zhang AJ; Wong WM; Kok KH; Lau SKP; Woo PCY; Lo JYC; Jin DY; Shih SR; Yuen KY
J Clin Invest; 2018 Nov; 128(11):5163-5177. PubMed ID: 30153112
[TBL] [Abstract][Full Text] [Related]
29. An auto-antibody identified from phenotypic directed screening platform shows host immunity against EV-A71 infection.
Cheng YW; Chuang YC; Huang SW; Liu CC; Wang JR
J Biomed Sci; 2022 Feb; 29(1):10. PubMed ID: 35130884
[TBL] [Abstract][Full Text] [Related]
30. Essential Role of Enterovirus 2A Protease in Counteracting Stress Granule Formation and the Induction of Type I Interferon.
Visser LJ; Langereis MA; Rabouw HH; Wahedi M; Muntjewerff EM; de Groot RJ; van Kuppeveld FJM
J Virol; 2019 May; 93(10):. PubMed ID: 30867299
[TBL] [Abstract][Full Text] [Related]
31. Autophagy is induced and supports virus replication in Enterovirus A71-infected human primary neuronal cells.
Lin JY; Huang HI
Sci Rep; 2020 Sep; 10(1):15234. PubMed ID: 32943650
[TBL] [Abstract][Full Text] [Related]
32. Changes in the EV-A71 Genome through Recombination and Spontaneous Mutations: Impact on Virulence.
Mandary MB; Poh CL
Viruses; 2018 Jun; 10(6):. PubMed ID: 29895721
[TBL] [Abstract][Full Text] [Related]
33. MRI reveals segmental distribution of enterovirus lesions in the central nervous system: a probable clinical evidence of retrograde axonal transport of EV-A71.
Li H; Su L; Zhang T; He F; Yin Y
J Neurovirol; 2019 Jun; 25(3):354-362. PubMed ID: 30734196
[TBL] [Abstract][Full Text] [Related]
34. Immune responses against enterovirus A71 infection: Implications for vaccine success.
Aw-Yong KL; NikNadia NMN; Tan CW; Sam IC; Chan YF
Rev Med Virol; 2019 Sep; 29(5):e2073. PubMed ID: 31369184
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of enterovirus-A71 in children with acute flaccid paralysis in the Philippines.
Apostol LN; Shimizu H; Suzuki A; Umami RN; Jiao MMA; Tandoc A; Saito M; Lupisan S; Oshitani H
BMC Infect Dis; 2019 May; 19(1):370. PubMed ID: 31046684
[TBL] [Abstract][Full Text] [Related]
36. Enterovirus A71: virulence, antigenicity, and genetic evolution over the years.
Huang SW; Cheng D; Wang JR
J Biomed Sci; 2019 Oct; 26(1):81. PubMed ID: 31630680
[TBL] [Abstract][Full Text] [Related]
37. Host neuronal PRSS3 interacts with enterovirus A71 3A protein and its role in viral replication.
Rattanakomol P; Srimanote P; Tongtawe P; Khantisitthiporn O; Supasorn O; Thanongsaksrikul J
Sci Rep; 2022 Jul; 12(1):12846. PubMed ID: 35896602
[TBL] [Abstract][Full Text] [Related]
38. Surveillance of enteroviruses from paediatric patients attended at a tertiary hospital in Catalonia from 2014 to 2017.
Andrés C; Vila J; Gimferrer L; Piñana M; Esperalba J; Codina MG; Barnés M; Martín MC; Fuentes F; Rubio S; Alcubilla P; Rodrigo C; Pumarola T; Antón A
J Clin Virol; 2019 Jan; 110():29-35. PubMed ID: 30530096
[TBL] [Abstract][Full Text] [Related]
39. Cardiopulmonary failure as a result of brainstem encephalitis caused by enterovirus D68.
Yogo N; Imamura T; Muto Y; Hirai K
BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31732545
[TBL] [Abstract][Full Text] [Related]
40. Recent Advances in Enterovirus A71 Infection and Antiviral Agents.
Wei Y; Liu H; Hu D; He Q; Yao C; Li H; Hu K; Wang J
Lab Invest; 2024 Feb; 104(2):100298. PubMed ID: 38008182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
